The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients

The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients

Background. At present, the diagnostic accuracy of alpha-fetoprotein (AFP) for hepatocellular carcinoma (HCC) surveillance is insufficient. It remains controversial whether prothrombin induced by vitamin K absence II (PIVKA-II) has a better diagnostic value than AFP for HCC patients. Objective. To i...

Full description

Bibliographic Details
Main Authors:	Fei Xu, Lulu Zhang, Wenting He, Di Song, Xiaomeng Ji, Jianyong Shao
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	Disease Markers
Online Access:	http://dx.doi.org/10.1155/2021/8868370

Similar Items

Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients
by: Shujing Huang, et al.
Published: (2017-05-01)

PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
by: Honglei Feng, et al.
Published: (2021-04-01)

The value of PIVKA-Ⅱ versus AFP for the diagnosis and detection of postoperative changes in hepatocellular carcinoma
by: Qiuyan Lee, et al.
Published: (2021-05-01)

Clinical Significance of AFP and PIVKA-II Responses for Monitoring Treatment Outcomes and Predicting Prognosis in Patients with Hepatocellular Carcinoma
by: Hana Park, et al.
Published: (2013-01-01)

Impact of PIVKA-II in diagnosis of hepatocellular carcinoma
by: Nadia I. Zakhary, et al.
Published: (2013-11-01)

Value of serum PIVKA-Ⅱ, alpha-fetoprotein, and ferritin in assisting the diagnosis of HBV-related hepatocellular carcinoma
by: WEN Jun, et al.
Published: (2017-09-01)

Hypermethylation of SCAND3 and Myo1g Gene Are Potential Diagnostic Biomarkers for Hepatocellular Carcinoma
by: Fei Xu, et al.
Published: (2020-08-01)

Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients
by: Xuqi Sun, et al.
Published: (2021-07-01)

Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data
by: Rentao Yu, et al.
Published: (2017-09-01)

Correlation of GGT with AFP and diagnostic value of GGT for hepatocellular carcinoma
by: GAO Chun
Published: (2014-09-01)

The clinical application of PIVKA-II in hepatocellular carcinoma and chronic liver diseases: A multi-center study in China
by: Gao, C., et al.
Published: (2021)

Values of serum AFP, GGTⅡ and GP73 in diagnosis of primary hepatocellular carcinoma
by: ZHU Chen
Published: (2014-10-01)

Identification of Plasma hsa_circ_0005397 and Combined With Serum AFP, AFP-L3 as Potential Biomarkers for Hepatocellular Carcinoma
by: Ruoyu Liu, et al.
Published: (2021-02-01)

PIVKA-II level is correlated to development of portal vein tumor thrombus in patients with HBV-related hepatocellular carcinoma
by: Tao Li, et al.
Published: (2019-05-01)

Serum AFU, 5’-NT and AFP as biomarkers for primary hepatocellular carcinoma diagnosis
by: Junna Zhu, et al.
Published: (2017-10-01)

Unclassified hepatocellular adenoma with histological brown pigment deposition and serum PIVKA-II level elevation: a case report
by: Kouki Hoshino, et al.
Published: (2020-05-01)

Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.
by: Roslyn Vongsuvanh, et al.
Published: (2016-01-01)

Multiplexed Proteomic Approach for Identification of Serum Biomarkers in Hepatocellular Carcinoma Patients with Normal AFP
by: Young-Sun Lee, et al.
Published: (2020-01-01)

Clinicopathological Distinction of Low-AFP-Secreting vs. High-AFP-Secreting Hepatocellular Carcinomas
by: Ahmet Gurakar, et al.
Published: (2018-11-01)

Value of combined detection of serum AFP and GP73 in early diagnosis of hepatocellular carcinoma
by: GAO Haifeng
Published: (2014-07-01)

TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
by: Liping Mao, et al.
Published: (2017-01-01)

New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma
by: Ting Wang, et al.
Published: (2020-08-01)

Serum Biomarkers AFP, CEA and CA19-9 Combined Detection for Early Diagnosis of Hepatocellular Carcinoma
by: Muhammad Ibrahim Alhadi EDOO, et al.
Published: (2019-02-01)

Evaluation of serum AFP (α-fetoprotein) level in HBsAg carrier patients for diagnosis of hepatocellular carcinoma
by: eskandar Hajiani, et al.
Published: (2006-06-01)

Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis
by: Xueying Wang, et al.
Published: (2020-01-01)

Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV‐related hepatocellular carcinoma
by: Yezhou Ding, et al.
Published: (2020-05-01)

Simple Clinical Metrics Enhance AFP to Effectively Identify Cirrhotic Patients With Complicating Hepatocellular Carcinoma at Various AFP Levels
by: Xi Zhang, et al.
Published: (2020-01-01)

Ontogenetic view on PIVKA-II in the development of prothrombin synthesis in infants
by: O. G. Ivanko, et al.
Published: (2017-12-01)

Prognostic role of pre-treatment serum AFP-L3% in hepatocellular carcinoma: systematic review and meta-analysis.
by: Jiwen Cheng, et al.
Published: (2014-01-01)

Novel Value of Preoperative Gamma-Glutamyltransferase Levels in the Prognosis of AFP-Negative Hepatocellular Carcinoma
by: Liang-He Lu, et al.
Published: (2020-01-01)

Elevated Preoperative Serum CA125 Predicts Larger Tumor Diameter in Patients with Hepatocellular Carcinoma and Low AFP Levels
by: Sanshun Zhou, et al.
Published: (2019-01-01)

Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinoma
by: Li Huang, et al.
Published: (2020-03-01)

PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma.
by: Sara Tartaglione, et al.
Published: (2021-01-01)

Diagnostic value of Joint Detection of GP73 and AFP-L3 in Primary Hepatic Carcinoma with Low Concentration of AFP
by: Lei CAI, et al.
Published: (2015-03-01)

Abnormal Prothrombin (PIVKA-II) Expression in Canine Tissues as an Indicator of Anticoagulant Poisoning
by: Lorella Maniscalco, et al.
Published: (2021-09-01)

Niveis plasmáticos de pivka-II em pacientes com hepatite autoimune
by: Sundell, Michelle de Oliveira Torres, 1980-
Published: (2011)

MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.
by: Chan Xie, et al.
Published: (2013-01-01)

Improving the Detection of Hepatocellular Carcinoma using serum AFP expression in combination with GPC3 and micro-RNA miR-122 expression
by: Li Jian, et al.
Published: (2019-03-01)

Diagnostic values of GP73, AFP-L3, AFP, and AFU for liver diseases
by: DING Yan
Published: (2014-08-01)

Comparing Prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins Glypican-3, Alpha feto protein and Carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patients
by: Iman A. Abd El Gawad, et al.
Published: (2014-06-01)